Organovo Initiates Contracting For Their 3D Bioprinted Human Liver Cells

RAPID

Share this Article

One of the more exciting companies within the 3D Printing space is Organovo. The San Diego based company is using 3D printing technology to print live human tissue. It sounds like something out of a science fiction organovo-1novel, but the company has been making tremendous progress over the last couple of years. Organovo’s ultimate goal is to be able to print out entire functioning human organs. Although such an accomplishment is still many years away, they are already turning heads, and garnering interest from major pharmaceutical companies that are looking to use their bioprinted tissue for pre-clinical trials .

Every year billions of dollars are spent performing pre-clinical testing for drug discovery. These tests usually rely on a variety of methods, most of which are not all that accurate. What Organovo has been working diligently on, has been the development of human tissue samples, specifically liver tissue, aimed towards pre-clinical drug testing and discovery. This week the company announced that they have begun initiating contracts for their patented 3D printed human liver tissue samples, with various pharmaceutical and biotech firms.

Organovo’s Chairman and Chief Executive Officer, Keith Murphy, stated “Organovo has received interest in advance of our planned launch from top 15 pharma company customers, small to midsize pharma companies, biotechnology companies, and private venture capital backed pharmaceutical development firms. The compelling data already generated on the organovo-featperformance of the 3D Human Liver Tissue has driven this interest, we believe, and I’m pleased that our team was able in a short time to accomplish all of the hard work that allowed us to begin signing contracts. We’ll be able to deliver results for proprietary compounds and other needs, while completing the work for fuller product and service launch on our original timeline.”

The company expects to expand their offerings to more clients as the year progresses. The human liver tissue that they are able to print, is capable of surviving long term studies, making them ideal for testing the long term affects of a drug on the human liver. This is a major step towards further monetization of their technology, and will likely allow them to push forward with additional bioprinting applications that they have shown interest in. Discuss this article at the Organovo forum thread at 3DPB.com.

organovo-2

3D Printed Human Liver Tissue

Share this Article


Recent News

Boring Company Alum Score $9M for Advanced Composites Manufacturing

3D Printing News Unpeeled: Hypersonics, Tidal Power, Indian Rocket Engine



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3DPOD Episode 198: High Speed Sintering with Neil Hopkinson, VP of AM at Stratasys

Neil Hopkinson, a pioneering 3D printing researcher, played a pivotal role in developing a body of research that is widely utilized today. He also invented High Speed Sintering (HSS), also...

GE Additive Transforms into Colibrium Additive in New Brand Move

One of the largest and most compelling companies in the 3D printing industry, GE Additive, has undergone a rebrand. Now, known as Colibrium Additive, the company and its new name...

HP & INDO-MIM Collaborate to Boost Metal 3D Printing in India

HP Inc. and INDO-MIM, a US- and India-based supplier of metal injection molding (MIM) powders and contract manufacturer, have announced that the two companies will collaborate to accelerate additive manufacturing...

Nylon 3D Printed Parts Made More Functional with Coatings & Colors

Parts 3D printed from polyamide (PA, Nylon) 12 using powder bed fusion (PBF) are a mainstay in the additive manufacturing (AM) industry. While post-finishing processes have improved the porosity of...